Period of time: 2014年4期
Publisher: Informa Healthcare
Founded in: 2002
Total resources: 54
ISSN: 1474-0338
Subject: R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Safety,volume 7,issue 4
Menu
We are now accepting original research!
By Knowles Elizabeth,Win Beta in (2008)
Expert Opinion on Drug Safety,volume 7,issue 4 , Vol. 7, Iss. 4, 2008-07 , pp.The root cause of patient safety concerns in an Internet pharmacy
Expert Opinion on Drug Safety,volume 7,issue 4 , Vol. 7, Iss. 4, 2008-07 , pp.The FDA Drug Safety Bill: how safe are our drugs?
Expert Opinion on Drug Safety,volume 7,issue 4 , Vol. 7, Iss. 4, 2008-07 , pp.Drug allergies – unknown dangers to patients
Expert Opinion on Drug Safety,volume 7,issue 4 , Vol. 7, Iss. 4, 2008-07 , pp.By Ainscow Edward K,Pilling James E,Brown Nick M,Orme Alexandra T,Sullivan Michael,Hargreaves Andy C,Cooke Emma-Louise,Sullivan Elaine,Carlsson Stefan,Andersson Tommy B in (2008)
Expert Opinion on Drug Safety,volume 7,issue 4 , Vol. 7, Iss. 4, 2008-07 , pp.The cardiovascular safety of rosiglitazone
By Ajjan Ramzi A,Grant Peter J in (2008)
Expert Opinion on Drug Safety,volume 7,issue 4 , Vol. 7, Iss. 4, 2008-07 , pp.The safety of cefepime in the treatment of infection
By Drago Lorenzo,Vecchi Elena De in (2008)
Expert Opinion on Drug Safety,volume 7,issue 4 , Vol. 7, Iss. 4, 2008-07 , pp.Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients
Expert Opinion on Drug Safety,volume 7,issue 4 , Vol. 7, Iss. 4, 2008-07 , pp.The safety of celecoxib in ankylosing spondylitis treatment
By Poddubnyy Denis A,Song In-Ho,Sieper Joachim in (2008)
Expert Opinion on Drug Safety,volume 7,issue 4 , Vol. 7, Iss. 4, 2008-07 , pp.Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus
By Aringer Martin,Smolen Josef S in (2008)
Expert Opinion on Drug Safety,volume 7,issue 4 , Vol. 7, Iss. 4, 2008-07 , pp.